Glaxo Avandia Restrictions Should be Modified, FDA Advisers Say

Glaxo Avandia Restrictions Should be Modified, FDA Advisers Say

JB Reed/Bloomberg

GlaxoSmithKline Plc's Avandia diabetes drug.